Introduction
The use of single dose antibiotic therapy for the treatment of acute uncomplicated gonorrhoea has been the subject of previous research (Kvale et al., 1971; Masterton and Schofield, 1972; Willcox et al., 1973) . This type of treatment results in the eradication of the gonococcus in 98 % of cases in both sexes (Gundersen et al., 1969; Kvale et al., 1971) .
For many years after its introduction, penicillin G was the treatment of choice in gonorrhoea. In 1961, with the advent of ampicillin, a valuable oral therapy was introduced. This semi-synthetic penicillin has now become recognised worldwide as standard oral treatment and single dose administration is recommended by the Venereal Disease Control Division, Center for Disease Control, Atlanta, USA (Center for Disease Control, 1972 , 1974 and also by the clinics in the United Kingdom, where it is often given with probenecid (Willcox et al., 1973) .
Talampicillin hydrochloride (Talpen) is a derivative of ampicillin which, being an ester of 6-amino penicillanic acid, is rapidly absorbed froin the gastrointestinal tract and is immediately hydrolysed in the mucosa and the blood to ampicillin and the ester moeity. This results in high serum concentrations of ampicillin relative to a comparable dose of ampicillin. As the eradication of the gonococcus from the urethra is related to the tissue level of ampicillin and the length of time that this is maintained, it was decided to undertake a clinical trial with talampicillin using a single dose of 1-48 g talampicillin, equivalent to 1 g ampicillin pure free acid, plus I g probenecid. The penicillin-that is, above 0 03 units/ml to 0-1 units/ml-10% showing a sensitivity from 0-1 to 1-0 units/ml, and 3% above this level (Price and Fluker, 1975) . Olsen and Lomholt (1969) Control, 1974) . Kvale et al. (1971) showed a success rate of 96% using 3-5 g of ampicillin in 1 g probenecid in 202 patients with gonococcal urethritis acquired in the Philippines, and where the same dose of ampicillin without probenecid was used a failure rate of 29.3 % resulted.
It is therefore interesting to see that with the administration of talampicillin, a dose of 1-5 g, equivalent to 1 g ampicillin, pure free acid is so well absorbed that when used with 1 g probenecid in men treated for urethral gonorrhoea, the failure rate is only 2 %. The advantage of the smaller dose to achieve such a good clinical response rate would be to reduce the incidence of any side effect and development of resistant strains. Further work with this method of administration should be undertaken as it appears to be a very satisfactory method of treatment. 
